Home >

news Help

Publication Information


Title
Japanese:New Boron Delivery Agents 
English:New Boron Delivery Agents 
Author
Japanese: Annette G. Beck-Sickinger, Daniel P. Becker, Oksana Chepurna, Bhaskar Das, Sebastian Flieger, Evamarie Hey-Hawkins, Narayan Hosmane, Satish S. Jalisatgi, Hiroyuki Nakamura, Rameshwar Patil, Maria da Graﾃｧa H. Vicente, Clara Viﾃｱas.  
English: Annette G. Beck-Sickinger, Daniel P. Becker, Oksana Chepurna, Bhaskar Das, Sebastian Flieger, Evamarie Hey-Hawkins, Narayan Hosmane, Satish S. Jalisatgi, Hiroyuki Nakamura, Rameshwar Patil, Maria da Graﾃｧa H. Vicente, Clara Viﾃｱas.  
Language English 
Journal/Book name
Japanese:Cancer Biotherapy and Radiopharmaceuticals 
English:Cancer Biotherapy and Radiopharmaceuticals 
Volume, Number, Page Vol. 38    No. 3    pp. 160-172
Published date Apr. 5, 2023 
Publisher
Japanese:Mary Ann Liebert, Inc., publishers 
English:Mary Ann Liebert, Inc., publishers 
Conference name
Japanese: 
English: 
Conference site
Japanese: 
English: 
Official URL https://doi.org/10.1089/cbr.2022.0060
 
DOI https://doi.org/10.1089/cbr.2022.0060
Abstract This proceeding article compiles current research on the development of boron delivery drugs for boron neutron capture therapy that was presented and discussed at the National Cancer Institute (NCI) Workshop on Neutron Capture Therapy that took place on April 20?22, 2022. The most used boron sources are icosahedral boron clusters attached to peptides, proteins (such as albumin), porphyrin derivatives, dendrimers, polymers, and nanoparticles, or encapsulated into liposomes. These boron clusters and/or carriers can be labeled with contrast agents allowing for the use of imaging techniques, such as PET, SPECT, and fluorescence, that enable quantification of tumor-localized boron and their use as theranostic agents.

©2007 Tokyo Institute of Technology All rights reserved.